Research on the screening results of two cancers in eligible women
适龄妇女两癌筛查筛查结果研究

摘要

目的 探讨适龄妇女两癌筛查筛查结果，并结合筛查结果制定相应的预防方案。方法 研究纳入2022年1月-2022年12月华中区域20-64周岁适龄妇女4500例，均进行两癌筛查工作，具体筛查方式包括宫颈癌检查：妇科检查，采用成熟稳定的新型核酸检测技术即“HPV检测法”、阴道镜检查，组织病理学检查；乳腺癌检查：采用乳腺视诊、触诊及乳腺彩超检查、钼靶检查方法，统计、分析检查结果。结果 经两癌筛查后，发现4500例适龄妇女中，检出HPV阳性病例528例（11.73%），阴道镜检查和组织病理检查75例，检出CINⅡ—Ⅲ 13例，鳞状细胞癌1例，宫颈微小浸润癌1例。4500名适龄妇女接受乳腺癌筛查，超声检查BI-RADS分级3级358例、4级6例，转诊钼靶，3级20例、4级9例，组织病理：乳腺纤维腺瘤8例，浸润性导管癌2例，结论 经适龄妇女两癌筛查后，发现适龄女性乳腺疾病与宫颈疾病发生风险较高。

Abstract

Objective To explore the screening results of two cancers in eligible women and develop corresponding prevention plans based on the screening results.
Methods The study included 4500 eligible women aged 20-64 in the region from January 2022 to December 2022, all of whom underwent two cancer screening. The specific screening methods included cervical cancer examination: gynecological examination, using mature and stable new nucleic acid testing techniques such as "HPV detection method", colposcopy examination, and histopathological examination; Breast cancer examination: adopt breast visual examination, palpation, breast color ultrasound examination, molybdenum target examination methods, statistics and analysis of examination results.
Results After screening for two types of cancer, it was found that among 4500 eligible women, 528 cases (11.73%) were HPV positive, 75 cases were detected by vaginal colposcopy and histopathological examination, 13 cases were CIN II-III, 1 case was squamous cell carcinoma, and 1 case was cervical microinvasive carcinoma. 4500 women of the right age were screened for breast cancer. 358 cases were BI-RADS grade 3, 6 cases were BI-RADS grade 4, and they were referred to molybdenum target. 20 cases were grade 3, 9 cases were grade 4. Histopathology: 8 cases of breast fibroadenoma, 2 cases of invasive ductal cancer.
Conclusion   After screening for two cancers in the right age women, it was found that the risk of breast gland disease and cervical disease in the right age women was high.